Hindsight Media
Subscribe

Eli LillyLLY

HealthcareNYSEFinancial year ends in December

A drugmaker whose medicines include Mounjaro and Zepbound for diabetes and weight loss, as well as treatments for cancer and Alzheimer’s disease.

Filings to the SEC

FilingPeriodFiled
Quarterly report 10-Q30 September 202629 October 2026
Announcement 8-K: Results29 October 2026
Quarterly report 10-Q30 June 20265 August 2026
Announcement 8-K: Results5 August 2026
Announcement 8-K: Other events20 May 2026
Announcement 8-K: Shareholder vote7 May 2026
Quarterly report 10-Q31 March 202630 April 2026
Announcement 8-K: Results30 April 2026
Annual report 10-K31 December 202512 February 2026
Announcement 8-K: Results4 February 2026
Announcement 8-K: Directors or officers21 November 2025
Quarterly report 10-Q30 September 202530 October 2025
Announcement 8-K: Results30 October 2025
Announcement 8-K: Other events20 August 2025
Quarterly report 10-Q30 June 20257 August 2025
Announcement 8-K: Results7 August 2025
Announcement 8-K: Shareholder vote8 May 2025
Quarterly report 10-Q31 March 20251 May 2025
Announcement 8-K: Results1 May 2025
Annual report 10-K31 December 202419 February 2025
Announcement 8-K: Other events12 February 2025
Announcement 8-K: Results6 February 2025
Announcement 8-K: Results14 January 2025
Announcement 8-K: Directors or officers19 November 2024
Quarterly report 10-Q30 September 202430 October 2024
Announcement 8-K: Results30 October 2024
Announcement 8-K: Directors or officers9 September 2024
Announcement 8-K: Directors or officers16 August 2024
Announcement 8-K: Other events14 August 2024
Quarterly report 10-Q30 June 20248 August 2024
Announcement 8-K: Results8 August 2024
Announcement 8-K: Directors or officers10 July 2024
Announcement 8-K: Directors or officers5 June 2024
Announcement 8-K: Shareholder vote9 May 2024
Quarterly report 10-Q31 March 202430 April 2024
Announcement 8-K: Results30 April 2024
Annual report 10-K31 December 202321 February 2024
Announcement 8-K: Other events9 February 2024
Announcement 8-K: Results6 February 2024
Quarterly report 10-Q30 September 20232 November 2023

The most recent 40. Every filing is on the SEC’s website.

Charts and live prices are delayed, from TradingView. Market values use each company’s last trade on IEX at the previous close, times the shares in issue from its filings; company figures come from SEC filings. This is information, not investment advice. Where our market data comes from

Company logos are trademarks of their owners, shown only to identify them; the files are from Wikimedia Commons.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.